EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A cheminformatics and network pharmacology approach to elucidate the mechanism of action of Mycobacterium tuberculosis γ-carbonic anhydrase inhibitors

Ajay Manaithiya, Ratul Bhowmik, Kunal Bhattacharya, Rajarshi Ray, Sagar Singh Shyamal, Fabrizio Carta, Claudiu T Supuran, Seppo Parkkila, Ashok Aspatwar

Frontiers in Pharmacology · 02.09.2024 · 15

DOI: 10.3389/fphar.2024.1457012 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Pharmacology, online erschienen am 02.09.2024. Verfasst von Ajay Manaithiya und 8 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Mycobacterium tuberculosis (Mtb) carbonic anhydrases (CAs) are critical enzymes that regulate pH by converting CO 2 to HCO 3 − , essential for Mtb’s survival in acidic environments. Inhibiting γ-CAs presents a potential target for novel antituberculosis drugs with unique mechanisms of action.

Objective

This study aimed to explore the biological connections underlying Mtb pathogenesis and investigate the mechanistic actions of antituberculosis compounds targeting the Cas9 protein.

Methods

We employed homology modeling and virtual screening to identify compounds with high binding affinities for Cas9 protein. This study used the homology modeling approach employing high-quality AlphaFold DB models for γ-CA. Furthermore, the systems biology approach was used for analyzing the integrated modelling of compounds, integrating data on genes, pathways, phenotypes, and molecular descriptors. Single-cell RNA sequencing was also conducted to profile gene expression.

Results

Three compounds, F10921405, F08060425, and F14437079, potentially binding to Cas9 protein, have been identified. F10921405 and F08060425 showed significant overlap in their effects on pathways related to the immune response, while F14437079 displayed distinct mechanistic pathways. Expression profiling revealed high levels of genes such as PDE4D, ROCK2, ITK, MAPK10, and SYK in response to F1092–1405 and F0806-0425, and MMP2 and CALCRL in response to F1443-7079. These genes, which play a role in immune modulation and lung tissue integrity, are essential to fight against Mtb.

Conclusion

The molecular relationship and pathways linked to the mentioned compounds give the study a holistic perspective of targeting Mtb, which is essential in designing specific therapeutic approaches. Subsequent research will involve experimental validation to demonstrate the efficacy of the promising candidates in Mtb infections.

Schlagwörter

Stichwörter der Autor:innen

Mycobacterium tuberculosisinflammatory responsessystem biologyvirtual screeningγ-CAs

Autor:innen und Institutionen

  • Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland.
  • Pratiksha Institute of Pharmaceutical Sciences, Guwahati, Assam, India.
  • Royal School of Pharmacy, The Assam Royal Global University, Guwahati, Assam, India.
  • Department of Pharmaceutical Engineering and Technology, Indian Institute of Technology (Banaras Hindu University), Varanasi, India.
  • Department of Neuroscience, Psychology, Drug Research, and Child's Health, Section of Pharmaceutical and Nutraceutical Sciences, University of Florence, Florence, Italy.
  • Fimlab Ltd., Tampere University Hospital, Tampere, Finland.

Zitieren

APA

Manaithiya, A., Bhowmik, R., Bhattacharya, K., Ray, R., Shyamal, S. S., Carta, F., Supuran, C. T., Parkkila, S., & Aspatwar, A. (2024). A cheminformatics and network pharmacology approach to elucidate the mechanism of action of Mycobacterium tuberculosis γ-carbonic anhydrase inhibitors. Frontiers in Pharmacology, 15. https://doi.org/10.3389/fphar.2024.1457012

Vancouver

Manaithiya A, Bhowmik R, Bhattacharya K, Ray R, Shyamal SS, Carta F, et al. A cheminformatics and network pharmacology approach to elucidate the mechanism of action of Mycobacterium tuberculosis γ-carbonic anhydrase inhibitors. Frontiers in Pharmacology. 2024;15. doi:10.3389/fphar.2024.1457012

BibTeX
@article{Manaithiya2024,
  author = {Manaithiya, Ajay and Bhowmik, Ratul and Bhattacharya, Kunal and Ray, Rajarshi and Shyamal, Sagar Singh and Carta, Fabrizio and Supuran, Claudiu T and Parkkila, Seppo and Aspatwar, Ashok},
  title = {A cheminformatics and network pharmacology approach to elucidate the mechanism of action of Mycobacterium tuberculosis γ-carbonic anhydrase inhibitors},
  journal = {Frontiers in Pharmacology},
  year = {2024},
  volume = {15},
  doi = {10.3389/fphar.2024.1457012}
}
Kostenlos starten →